Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Drug Therapy01:28

Drug Therapy

445
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
445
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.5K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

972
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
972
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder.

Acta neuropsychiatrica·2020
Same author

The identification, assessment and management of difficult-to-treat depression: An international consensus statement.

Journal of affective disorders·2020
Same author

Cognitive and emotional impairments underpinning suicidal activity in patients with mood disorders: an fMRI study.

Acta psychiatrica Scandinavica·2019
Same author

Cognitive effects of adjunctive N-acetyl cysteine in psychosis.

Psychological medicine·2016
Same author

Association of FKBP5 polymorphisms and resting-state activity in a frontotemporal-parietal network.

Translational psychiatry·2016
Same author

Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis.

Molecular psychiatry·2016
Same journal

Biological and social rhythm differences, daily melatonin secretion and psychiatric symptoms in healthy adults.

International journal of psychiatry in clinical practice·2026
Same journal

Diagnostic utility of pan-immune inflammation value in drug-naïve first-episode psychosis.

International journal of psychiatry in clinical practice·2026
Same journal

Examining neuroretinal alterations in autism spectrum disorder: a systematic review of OCT and OCT-A studies.

International journal of psychiatry in clinical practice·2026
Same journal

Depressive symptoms in patients with schizophrenia spectrum disorders and the impact on treatment motivation and satisfaction.

International journal of psychiatry in clinical practice·2026
Same journal

Predictors of premature treatment termination in an inpatient programme for women with PTSD and/or eating disorders.

International journal of psychiatry in clinical practice·2026
Same journal

Evaluation of haematological parameters in patients with first-episode psychosis: distinctions between bipolar disorder and schizophrenia spectrum disorders.

International journal of psychiatry in clinical practice·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.0K

Management of resistant depression.

G S Malhi1, P K Bridges

  • 1Geoffrey Knight Unit, Maudsley Hospital, London.

International Journal of Psychiatry in Clinical Practice
|June 20, 2014
PubMed
Summary
This summary is machine-generated.

Accurate assessment and management are crucial to avoid misdiagnosing treatment-resistant depression. This study reviews antidepressant therapy principles, emphasizing systematic medication use and therapeutic drug monitoring for effective patient outcomes.

Keywords:
antidepressantsdoseresistant depressiontherapeutic drug monitoringtreatment

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

200

Related Experiment Videos

Last Updated: Apr 28, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.0K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

200

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Inadequate assessment and management of depression frequently lead to misdiagnosis of treatment resistance.
  • Accurate diagnosis is essential for effective depression management.

Purpose of the Study:

  • To define and diagnose treatment-resistant depression.
  • To outline principles and methods for effective antidepressant therapy.
  • To highlight the importance of therapeutic drug monitoring in clinical practice.

Main Methods:

  • Review of current literature on depression diagnosis and treatment.
  • Description of systematic antidepressant medication strategies.
  • Emphasis on therapeutic drug monitoring (TDM) principles and application.

Main Results:

  • Inadequate assessment contributes to the erroneous diagnosis of treatment resistance.
  • Systematic application of antidepressant therapy and TDM are key components of effective management.
  • Clinical examples illustrate the practical application of these principles.

Conclusions:

  • Proper assessment and management strategies can prevent misdiagnosis of treatment-resistant depression.
  • Systematic antidepressant therapy, guided by TDM, improves treatment efficacy.
  • Adherence to evidence-based principles is vital for optimizing patient outcomes in depression care.